Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VentaProst in COVID-19 requiring mechanical ventilation
NCT04452669Phase 2Completed
- Sponsor
- Aerogen
- Start
- Sep 2020
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of epoprostenol in coronavirus disease 2019 (COVID-19), sponsored by Aerogen. Started Sep 2020; status: completed.
02
Drugs
epoprostenol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04452669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04452669.